We aim to become the global biotech company based on proprietary technology.
R&D based company with mass cell culture technology and cell quality management technology
Patented in countries leading new drug development market
Enter the global biotech market with Proprietary technology
Cell2in is committed to protect our core technology by establishment of intellectual property in the field of cell therapy
Cell2in has continuously published its research results through famous academic societies and journals.